Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease

BACKGROUND: Guidelines regarding the use of infliximab in Crohn’s disease were previously published by the Canadian Association of Gastroenterology in 2004. However, recent clinical findings and drug developments warrant a review and update of these guidelines.

Xehetasun bibliografikoak

Egile Nagusiak:	Daniel C Sadowski, Charles N Bernstein, Alain Bitton, Ken Croitoru, Richard N Fedorak, Anne Griffiths, the CAG Crohn’s Consensus Group
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2009-01-01
Saila:	Canadian Journal of Gastroenterology
Sarrera elektronikoa:	http://dx.doi.org/10.1155/2009/201430
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!